tetrabenazine has been researched along with Abnormal Movements in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, H; Sakata, M | 1 |
| Albayrak, Y; Beyazyüz, E; Çelikkol, A; Mengi, M; Uslu, ET | 1 |
| Bhidayasiri, R; Caroff, SN; Correll, CU; Fahn, S; Frei, KP; Hauser, RA; Jankovic, J; Kane, JM; Truong, DD | 1 |
| Dorfman, BJ; Jimenez-Shahed, J | 1 |
| Ciacciarelli, A; Currò, CT; Girlanda, P; Nicocia, G; Russo, G; Terranova, C; Toscano, A; Ziccone, V | 1 |
| Carbon, M; Correll, CU | 1 |
| Anderson, KE; Davis, MD; Factor, SA; Fernandez, HH; Hauser, RA; Isojärvi, J; Jarskog, LF; Jimenez-Shahed, J; Kumar, R; McEvoy, JP; Ochudlo, S; Ondo, WG; Stamler, D | 1 |
| Fasano, A; Levy, A | 1 |
| Citrome, L | 1 |
| de la Fuente-Fernandez, R; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Troiano, AR | 1 |
| Vingerhoets, FJ | 1 |
| Arbizu, J; Blesa, J; Cavada, C; Collantes, M; García-García, D; Iglesias, E; Juri, C; Martí-Climent, J; Obeso, JA; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
| Andrich, J; Reber, D; Saft, C; Streuer, M | 1 |
| Michael, BD; Milburn-McNulty, P; Nicolson, A; Woodford, HJ | 1 |
| Ondo, WG; Sitburana, O | 1 |
| Geoghegan, MF; Khaw, CH; McCormick, PA | 1 |
1 review(s) available for tetrabenazine and Abnormal Movements
| Article | Year |
|---|---|
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.
Topics: Antipsychotic Agents; Dyskinesias; Humans; Movement Disorders; Outcome Assessment, Health Care; Tardive Dyskinesia; Tetrabenazine | 2020 |
1 trial(s) available for tetrabenazine and Abnormal Movements
| Article | Year |
|---|---|
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Double-Blind Method; Dyskinesias; Europe; Female; Humans; Male; Middle Aged; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; United States | 2017 |
14 other study(ies) available for tetrabenazine and Abnormal Movements
| Article | Year |
|---|---|
[Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].
Topics: Antipsychotic Agents; Dyskinesias; Humans; Schizophrenia; Tardive Dyskinesia; Tetrabenazine | 2022 |
The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Dyskinesias; Fluvoxamine; Haloperidol; Male; Nerve Growth Factor; Rats; Rats, Wistar; Superoxide Dismutase; Tardive Dyskinesia; Tetrabenazine | 2023 |
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia.
Topics: Dyskinesias; Humans; Tardive Dyskinesia; Tetrabenazine; United States; Vesicular Monoamine Transport Proteins | 2021 |
Pimozide and pancreatic cancer in diabetic chorea: a case report.
Topics: Aged; Blood Glucose; Chorea; Diabetes Mellitus; Dyskinesias; Female; Humans; Pancreatic Neoplasms; Pimozide; Tetrabenazine | 2022 |
A new class of VMAT-2 inhibitors for tardive dyskinesia.
Topics: Antipsychotic Agents; Double-Blind Method; Dyskinesias; Humans; Tardive Dyskinesia; Tetrabenazine | 2017 |
Tetrabenazine and subthalamic stimulation in graft-induced dyskinesias.
Topics: Deep Brain Stimulation; Dyskinesias; Electric Stimulation Therapy; Humans; Parkinson Disease; Subthalamic Nucleus; Tetrabenazine | 2017 |
Vesicular monoamine transporter type 2 inhibition can lead to effective and tolerable management of tardive dyskinesia.
Topics: Double-Blind Method; Dyskinesias; Humans; Tardive Dyskinesia; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2018 |
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
Topics: Caudate Nucleus; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Female; Humans; Logistic Models; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tetrabenazine | 2009 |
Dyskinesia in Parkinson disease: back for the future?
Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesias; Humans; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Synapses; Tetrabenazine | 2009 |
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Topics: Animals; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dyskinesias; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Severity of Illness Index; Signal Processing, Computer-Assisted; Tetrabenazine | 2010 |
Post pump chorea in a 77-year-old male.
Topics: Aged; Anti-Dyskinesia Agents; Aortic Valve; Cardiopulmonary Bypass; Chorea; Delirium; Dyskinesias; Heart Valve Prosthesis Implantation; Humans; Male; Neurologic Examination; Risk Factors; Surgical Instruments; Tetrabenazine | 2011 |
Hyperosmolar non-ketotic hyperglycaemia: an important and reversible cause of acute bilateral ballismus.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Aged, 80 and over; Diabetes Mellitus, Type 2; Dyskinesias; Female; Humans; Hyperglycemia; Insulin; Osmolar Concentration; Tetrabenazine | 2012 |
Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus.
Topics: Aged; Anti-Dyskinesia Agents; Chorea; Dyskinesias; Female; Functional Laterality; Humans; Hyperglycemia; Magnetic Resonance Imaging; Tetrabenazine | 2006 |
Hemiballismus.
Topics: Aged; Aged, 80 and over; Anti-Dyskinesia Agents; Dyskinesias; Electrocardiography; Female; Humans; Tetrabenazine | 2002 |